Bayer Group Consolidated Statements of Recognized Income and Expense

	2nd Quarter 2007	2nd Quarter 2008	1st Half 2007	1st Half 2008
€ million
Changes in fair values of derivatives designated as hedges and available-for-sale financial assets, recognized in stockholders’ equity	(3)	78	(2)	120
Changes in actuarial gains/losses on defined benefit obligations for pensions and other post-employment benefits and effects of the limitation on pension plan assets, recognized in stockholders’ equity	774	128	1,105	945
Exchange differences on translation of operations outside the euro zone, recognized in stockholders’ equity	(36)	121	7	(431)
Deferred taxes on valuation adjustments offset directly against stockholders’ equity	(297)	(62)	(431)	(323)
Changes due to changes in scope of consolidation	5	(1)	36	0
Revaluation surplus (IFRS 3)	-	2	-	6
Minority interest in partnerships, recognized in liabilities	(12)	(9)	(19)	(29)
Valuation adjustments recognized directly in stockholders’ equity	431	257	696	288
Income after taxes	657	581	3,467	1,343
Total income and expense recognized in the financial statements	1,088	838	4,163	1,631
of which attributable to minority interest	(4)	2	(2)	1
of which attributable to Bayer AG stockholders	1,092	836	4,165	1,630